Cancers · 2010 · 16 citations · 113 references
MedicineCancer BiologyOncologyBreast OncologyMetabolic RegulationMetabolismCancer MetabolismMetabolic DiseaseMetabolic EndocrinologyMetabolic Reprogramming In CancerMetabolic SignalingMetabolic SyndromeAbdominal AdiposityBlood PressureCancer Metabolic PhenotypingDisease Biomarker DiscoveryIncreased AdiposityMetabolic Alterations In CancerMetabolic Disease BiomarkersObesity-related Carcinogenesis
In spite of its public health importance, our understanding of the mechanisms of breast carcinogenesis and progress is still evolving. The metabolic syndrome (MS) is a constellation of biochemical abnormalities including visceral adiposity, hyperglycemia, hyperinsulinemia, dyslipidemia and high blood pressure. The components of the MS have all been related to late-stage disease and even to a poor prognosis of breast cancer through multiple interacting mechanisms. In this review, we aim to present a summary of recent advances in the understanding of the contribution of the MS to breast cancer with the emphasis on the role of biomarkers of the MS in the prognosis of breast cancer.
113
K. G. M. M. Alberti, Paul Zimmet · Diabetic Medicine · 1998 · 15.3K citations
Harmonizing the Metabolic Syndrome
K. G. M. M. Alberti, Robert H. Eckel, Scott M. Grundy et al. · Circulation · 2009 · 14.7K citations · Full text
Otto Warbürg · Science · 1956 · 13.3K citations
The metabolic syndrome—a new worldwide definition
K. G. M. M. Alberti, Paul Zimmet, Jonathan E. Shaw · The Lancet · 2005 · 9.3K citations
Robert H. Eckel, KGMM Alberti, Scott M. Grundy et al. · The Lancet · 2010 · 6.3K citations